# Bone Marrow Transplantation in Treating Patients With Leukemia

> **NCT00006451** · PHASE3 · WITHDRAWN · sponsor: **Masonic Cancer Center, University of Minnesota**

## Conditions studied

- Graft Versus Host Disease
- Leukemia
- Lymphoma

## Interventions

- **DRUG:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** methotrexate
- **DRUG:** methylprednisolone
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** in vitro-treated bone marrow transplantation
- **PROCEDURE:** radiation therapy

## Key facts

- **NCT ID:** NCT00006451
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1996-04
- **Primary completion:** 2000-11
- **Final completion:** 2000-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated (due to no accrual)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006451, "Bone Marrow Transplantation in Treating Patients With Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00006451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*